Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Considerations for Cell and Gene Therapy Programs Entering the Clinical Space

13 Jun 2023

Abstract excerpt

Cell and gene therapy (CGT) describes a broad category of medicinal products with potential applications to prevent and treat human disease in multiple therapeutic areas. These therapies leverage the use of modified nucleic acids, altered cells or tissue, or both. The modality, mechanism, route of administration, and therapeutic indication for a CGT product will influence the challenges and opportunities for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CAR-T cell therapy research
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37309988
DOI: 10.1002/cpt.2971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Considerations for Cell and Gene Therapy Programs Entering the Clinical SpacePMID 37309988Read ↗

Development of Cell and Gene Therapies for Clinical Use in the US and EU: Summary of Regulatory GuidelinesSemantic proximity Read ↗

Considerations for manufacturing of cell and gene medicines for clinical developmentSemantic proximity Read ↗

Clinical development of gene- and cell-based therapies: overview of the European landscapeSemantic proximity Read ↗

Challenges and Pathways in Regulating Next-Gen Biological TherapiesSemantic proximity Read ↗

An International Society for Cell & Gene Therapy working group short report on the future of expanded access to unapproved cell and gene therapiesSemantic proximity Read ↗

Scientific and Regulatory Policy Committee Points to Consider: Nonclinical Research and Development of In Vivo Gene Therapy Products, Emphasizing Adeno-Associated Virus VectorsSemantic proximity Read ↗

Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapiesSemantic proximity Read ↗

Development and Clinical Translation of Approved Gene Therapy Products for Genetic DisordersSemantic proximity Read ↗

EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cellsSemantic proximity Read ↗

The era of gene therapy: From preclinical development to clinical applicationSemantic proximity Read ↗

A few ethical issues in translational research for gene and cell therapySemantic proximity Read ↗

Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.